Ohcanbohtosat - Clive McCarthy
- Čájehuvvo 1 - 2 / 2
-
1
-
2
A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients Dahkki Ralph Tiedt, Elisa Degenkolbe, Pascal Furet, B.A. Appleton, Sabrina Wagner, Joseph Schoepfer, Emily Buck, David A. Ruddy, John E. Monahan, Michael D. Jones, Jutta Blank, Dorothea Haasen, Peter Drueckes, Markus Wartmann, Clive McCarthy, William R. Sellers, Francesco Hofmann
Almmustuhtton 2011Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
ABL
Airway
Anesthesia
Cancer
Cancer research
Cystic fibrosis
Cystic fibrosis transmembrane conductance regulator
Dasatinib
Drug resistance
Ecology
Endocrinology
Gene
Genetics
Imatinib
Imatinib mesylate
Internal medicine
Ivacaftor
Kinase
Lung
Medicine
Missense mutation
Mucociliary clearance
Mucus
Mutant
Mutation
Myeloid leukemia
Pharmacology
Point mutation
Potentiator